Mediation between Bayer, plaintiffs seeks to clarify all justified claims: U.S. mediator
Mediation between Bayer and plaintiffs in the United States aims to clarify all justified claims related to Roundup herbicide both at the national and state level, mediator Ken Feinberg told a German magazine.
"The mediation is going slowly but steadily," Wirtschaftswoche on Wednesday quoted Feinberg as saying.
Bayer is trying to reach a settlement after earlier court rulings against it. The German drugs and pesticides maker, which acquired Roundup and other glyphosate-based weed killers as part of its $63 billion takeover of Monsanto last year, faces potentially heavy litigation costs as plaintiffs claim Roundup causes cancer, something Bayer disputes.